Cargando…
Gender differences in prednisone adverse effects: Survey result from the MG registry
OBJECTIVE: Prednisone is a first-line immunosuppressive treatment for myasthenia gravis (MG), whereas short-term and long-term adverse effects (AEs) are a limiting factor in its usage. METHOD: The MG patient registry is a patient-driven, nation-wide database with patients of age ≥18 years, who were...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192695/ https://www.ncbi.nlm.nih.gov/pubmed/30345333 http://dx.doi.org/10.1212/NXI.0000000000000507 |